Related Experiment Videos

Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation

M Glanemann1, J M Langrehr, R Raakow

  • 1Department of Surgery, Charité, Humboldt University, Berlin, Germany.

Transplantation Proceedings
|September 2, 1998
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos